Skip to main content
. 2022 Apr 30;34(2):95–108. doi: 10.21147/j.issn.1000-9604.2022.02.04

Figure S4.

Figure S4

Comparison of PFS and OS curves between CTCEpCAM+ and CTCEpCAM− patients. (A) PFS of CTCEpCAM+ and CTCEpCAM− patients was not statistically different (HR=1.049; 95% CI: 0.659−1.670; P=0.841); (B) OS of CTCEpCAM+ and CTCEpCAM− patients was not statistically different (HR=0.960; 95% CI: 0.505−1.823; P=0.899). PFS, progression-free survival; OS, overall survival; CTC, circulating tumor cell; HR, hazard ratio; 95% CI, 95% confidence interval.